Inventor · disambiguated record
Yoshimasa Saito
Also filed as: SAITO YOSHIMASA
18 granted patents·5 pending applications·211 citations·filing 1985–2005
95Inventor score
Files withFUJISAWA PHARMACEUTICAL CO19ASTELLAS PHARMA INC1NAT INST OF ADVANCED IND SCIEN1SHOWA DENKO KK1
Top patents by PatentIndex Score
23 records- 0183US7037892B2Hematopoietic stem cell proliferating agentsASTELLAS PHARMA INC·Filed 2002·Granted May 2, 2006·12 cites·7 claims
- 0276US4954391AHigh density polyethylene type transparent film and process for production thereofSHOWA DENKO KK·Filed 1986·Granted Sep 4, 1990·33 cites·14 claims
- 0371US6495365B1Hematopoietic stem cell proliferating agentsFUJISAWA PHARMACEUTICAL CO·Filed 1997·Granted Dec 17, 2002·28 cites·16 claims
- 0467US6825018B1Sorbitol dehydrogenase, gene encoding the same and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 2000·Granted Nov 30, 2004·2 cites·5 claims
- 0565US5019500AIGF-I fusion proteins; protection of IGF-I from degradation by host cell proteases; and processes for the production thereofFUJISAWA PHARMACEUTICAL CO·Filed 1988·Granted May 28, 1991·18 cites·11 claims
- 0663US5888786AMethod for producing 2-keto-L-gulonic acidFUJISAWA PHARMACEUTICAL CO·Filed 1997·Granted Mar 30, 1999·8 cites·22 claims
- 0762US5753481AL-sorbose dehydrogenase and novel L-sorbosone dehydrogenase obtained from gluconobacter oxydans T-100FUJISAWA PHARMACEUTICAL CO·Filed 1994·Granted May 19, 1998·16 cites·10 claims
- 0862US4745179A59 Valine insulin-like growth factor I and process for production thereofFUJISAWA PHARMACEUTICAL CO·Filed 1985·Granted May 17, 1988·21 cites·3 claims
- 0960US5861292AL-sorbose dehydrogenase and novel L-sorbosone dehydrogenase obtained from Gluconobacter oxydans T-100FUJISAWA PHARMACEUTICAL CO·Filed 1997·Granted Jan 19, 1999·10 cites·12 claims
- 1058US5648250ATissue plasminogen activatorFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Jul 15, 1997·13 cites·17 claims
- 1158US2003113912A1Hematopoietic stem cell proliferating agentsFUJISAWA PHARMACEUTICAL CO·Filed 2002·Application pending·0 cites
- 1257US2003170811A1Process for the production of alpha-human atrial natriuretic polypeptideFUJISAWA PHARMACEUTICAL CO·Filed 2002·Application pending·0 cites
- 1354US2004235105A1Sorbitol dehydrogenase, gene encoding the same and use thereofFUJISAWA PHARMACEUTICAL CO·Filed 2004·Application pending·0 cites
- 1452US5840533ATissue plasminogen activatorFUJISAWA PHARMACEUTICAL CO·Filed 1997·Granted Nov 24, 1998·9 cites·4 claims
- 1552US5336613ACephalosporin C acylaseFUJISAWA PHARMACEUTICAL CO·Filed 1993·Granted Aug 9, 1994·12 cites·11 claims
- 1649US5834263AMethod for producing 2-keto-L-gulonic acidFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Nov 10, 1998·12 cites·10 claims
- 1743US6197562B1L-sorbose dehydrogenase and novel L-sorbosone dehydrogenase obtained from gluconobacter oxydans T-100FUJISAWA PHARMACEUTICAL CO·Filed 1998·Granted Mar 6, 2001·7 cites·2 claims
- 1842US2009223823A1Method of separating protein, method of staining protein and liquid protein-staining agent and protein-staining kit to be used in these methodsNAT INST OF ADVANCED IND SCIEN·Filed 2005·Application pending·0 cites
- 1939US5804429ACephalosporin C acylaseFUJISAWA PHARMACEUTICAL CO·Filed 1994·Granted Sep 8, 1998·5 cites·8 claims
- 2039US5340725AExpression vector for insulin-like growth factor I and method of productionFUJISAWA PHARMACEUTICAL CO·Filed 1993·Granted Aug 23, 1994·4 cites·10 claims
- 2137US6403336B1Process for the production of α-human atrial natriuretic polypeptideFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Jun 11, 2002·1 cites·12 claims
- 2226US6399340B1Vector derivatives of gluconobacter plasmid pF4FUJISAWA PHARMACEUTICAL CO·Filed 1998·Granted Jun 4, 2002·0 cites·20 claims
- 2324US2002081676A1Method for producing an oxide with a fermentation processFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yoshimasa Saito files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →